<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/AD1B5C1D-39E1-4A1F-A58F-D5F2DE64FE7F"><gtr:id>AD1B5C1D-39E1-4A1F-A58F-D5F2DE64FE7F</gtr:id><gtr:name>Innsbruck Medical University</gtr:name><gtr:address><gtr:line1>Christoph-Probst-Platz 1</gtr:line1><gtr:line2>Innrain 52</gtr:line2><gtr:postCode>A-6020</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/2DD4D02A-0A99-41CD-A264-0EAFAD33D4B6"><gtr:id>2DD4D02A-0A99-41CD-A264-0EAFAD33D4B6</gtr:id><gtr:name>Faculty of Health Sciences</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Biochemistry</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/AD1B5C1D-39E1-4A1F-A58F-D5F2DE64FE7F"><gtr:id>AD1B5C1D-39E1-4A1F-A58F-D5F2DE64FE7F</gtr:id><gtr:name>Innsbruck Medical University</gtr:name><gtr:address><gtr:line1>Christoph-Probst-Platz 1</gtr:line1><gtr:line2>Innrain 52</gtr:line2><gtr:postCode>A-6020</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/2DD4D02A-0A99-41CD-A264-0EAFAD33D4B6"><gtr:id>2DD4D02A-0A99-41CD-A264-0EAFAD33D4B6</gtr:id><gtr:name>Faculty of Health Sciences</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/6AC5AA67-3B2B-450A-845F-DBE967A7CB60"><gtr:id>6AC5AA67-3B2B-450A-845F-DBE967A7CB60</gtr:id><gtr:firstName>Jean</gtr:firstName><gtr:otherNames>Olwen</gtr:otherNames><gtr:surname>Thomas</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0401547"><gtr:id>52FAB1AC-F681-4931-8563-D26681A23162</gtr:id><gtr:title>The role of linker histone variants and their phosphorylation in chromatin structure and function</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0401547</gtr:grantReference><gtr:abstractText>The DNA in organisms from yeast to man is packaged as a complex with an equal mass of basic proteins (histones). The complex is organized as ?beads on a string?, where each bead (nucleosome) has a protein core containing two copies of each of four histone types around which two turns of DNA are spooled. Complexed to the outside is one copy of another histone, H1, termed a ?linker histone? because it also associates partly with the linker DNA between beads. H1 has several roles: in nucleosome structure, nucleosome positioning along the DNA and chromatin folding into higher-order structures. There are several H1 variants, all with the same general structure (a central globular domain flanked by basic N-terminal and long C-terminal positively charged ?tail? regions). 

All the histones are subject to numerous enzymic (epigenetic) modifications, which can modify the properties of chromatin, directly or indirectly These modifications are crucial to appropriate gene expression. This project will study the linker histones, which are characterised by several rather similar variants in most cell types, as well as by more extreme variants sometimes present as single species in certain developmental stages of particular cell types. H1 is reversibly modified by phosphorylation, which occurs in a cell-cycle-dependent manner on serine and threonine residues in the positively charged tails, and is likely to alter the interaction of the tails with chromatin. This project aims to elucidate the role of linker histone variants and their phosphorylation in chromatin architecture and function.
 
The project will draw on the complementary expertise and technology of three laboratories with many years? experience of studying various aspects of linker histones: my laboratory in Cambridge and Professor H. Lindner?s laboratory in Austria, in collaboration with Professor I. Rundquist?s laboratory in Sweden. The Cambridge contribution will focus mainly on the structure, and DNA- and chromatin-binding properties of phosphorylated versus unphosphorylated linker histone tail domains. In addition we will aim to use NMR spectroscopy to determine how the linker histone tails emerge from the structured globular core, much needed information in determining exactly how H1 binds in chromatin. Understanding the role of linker histones and their phosphorylation is of central importance in understanding how cellular process are controlled by chromatin modification and relevant to an understanding of appropriate gene regulation in normal cells, as well as aberrant expression in disease.</gtr:abstractText><gtr:technicalSummary>(EuroDYNA Collaborative Research project: Abstract exactly as submitted in the application)

The linker histones are known to contribute to the formation and maintenance of higher order chromatin structures but their physiological functions are still largely unknown. They display a complex pattern of variants and recent data suggest that they may have specific roles in epigenetic control of gene expression. The cell cycle dependent phosphorylation of certain serine and threonine residues in the charged tails of the linker histones is most probably of major importance in determining the architecture of chromatin during cell proliferation and differentiation, but the molecular details of this process are very unclear. Aberrant chromatin structure may contribute to malignant transformation and tumour formation. This project aims at elucidating these mechanisms by combining the expertise of Herbert Lindner?s laboratory in Innsbruck and Jean Thomas? laboratory in Cambridge, in collaboration with Ingemar Rundquist?s laboratory in Linkoping. All three research groups have many years? experience in linker histone research and the laboratories complement each other well, offering a large range of methods and techniques in analytical chemistry, structural biology, biophysics, and cytochemistry. Together, these investigations should contribute to increased understanding of epigenetic mechanisms involved in chromatin architecture, regulation of cell growth and differentiation, and in malignant transformation and tumour progression.</gtr:technicalSummary><gtr:fund><gtr:end>2008-05-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-06-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>183000</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Innsbruck Medical University</gtr:collaboratingOrganisation><gtr:country>Austria, Republic of</gtr:country><gtr:department>Division of Clinical Biochemistry</gtr:department><gtr:description>ESF EuroDyna consortium</gtr:description><gtr:id>70DB3810-167F-43F5-9CB8-C112BA974B00</gtr:id><gtr:impact>NA</gtr:impact><gtr:partnerContribution>The role of linker histone variants and their phosphorylation in chromatin structure and
function
The role of linker histone variants and their phosphorylation in chromatin structure and
function</gtr:partnerContribution><gtr:piContribution>All three research groups have many years' experience in linker histone research and the laboratories complement each other well, offering a large range of methods and techniques in analytical chemistry, structural biology, biophysics, and cytochemistry. Together, these investigations should contribute to increased understanding of epigenetic mechanisms involved in chromatin architecture, regulation of cell growth and differentiation, and in malignant transformation and tumour progression.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Faculty of Health Sciences</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:department>Department of Clinical and Experimental Medicine</gtr:department><gtr:description>ESF EuroDyna consortium</gtr:description><gtr:id>8F3EDD97-7DC2-4D90-8627-2A80E7E68D55</gtr:id><gtr:impact>NA</gtr:impact><gtr:partnerContribution>The role of linker histone variants and their phosphorylation in chromatin structure and
function
The role of linker histone variants and their phosphorylation in chromatin structure and
function</gtr:partnerContribution><gtr:piContribution>All three research groups have many years' experience in linker histone research and the laboratories complement each other well, offering a large range of methods and techniques in analytical chemistry, structural biology, biophysics, and cytochemistry. Together, these investigations should contribute to increased understanding of epigenetic mechanisms involved in chromatin architecture, regulation of cell growth and differentiation, and in malignant transformation and tumour progression.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>President of Techniquest Science Centre, Cardiff 2005-8</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>57B56252-EFE1-4A27-A606-35719EBD04D4</gtr:id><gtr:impact>Tecchniquest stimulates schoolchildren's interest in science

Growing numbers of schools visits</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>Pre-2006,2006,2007,2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>I promoted public engagement activities through my membership of the Board of Governors of the Wellcome Trust 2000-2007</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>FD86A158-E8D8-40E1-B9AA-3F1E624F0B6C</gtr:id><gtr:impact>Wellcome Trust's successful Public Engagement activities are widely recognised.


PLEASE NOTE: I am not taking personal credit for either!! Although this entry under Engagement Activities may not be what was expected, I believe my involvement at a high level as described is valuable and an appropriate contribution.

Nothing specific to report.</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>Pre-2006,2006,2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Amalgamated Societies Lecture (evening), &quot;DNA, chromatin and chromosomes&quot;. 29 January 2008, St Catharine's College, University of Cambridge, UK</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>A5FE0764-BBB8-4E2D-AD54-1E324E3673F3</gtr:id><gtr:impact>Amalgamated Societies Lecture (evening), &amp;quot;DNA, chromatin and chromosomes&amp;quot;. 29 January 2008, St Catharine's College, University of Cambridge, UK. Open to non-scientists.
Talk sparked questions and stimulated discussions.

NA</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/99DF01BB-DC8C-4027-A541-4D51A39EA146"><gtr:id>99DF01BB-DC8C-4027-A541-4D51A39EA146</gtr:id><gtr:title>H1 and HMGB1: modulators of chromatin structure.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8ab10aadaf2361fcb37221fe09ef080b"><gtr:id>8ab10aadaf2361fcb37221fe09ef080b</gtr:id><gtr:otherNames>Thomas JO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0E31AAE7-76D7-47BF-86F5-C984F939F2AA"><gtr:id>0E31AAE7-76D7-47BF-86F5-C984F939F2AA</gtr:id><gtr:title>The interaction of HMGB1 and linker histones occurs through their acidic and basic tails.</gtr:title><gtr:parentPublicationTitle>Journal of molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a7ca0b82f30661f02e043666f9fa9212"><gtr:id>a7ca0b82f30661f02e043666f9fa9212</gtr:id><gtr:otherNames>Cato L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-2836</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0401547</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>